AI Terminal
BerGenBio
Director's Dealing • Jan 7, 2022
3555_dirs_2022-01-07_5213ccb2-dffd-4f4f-8e6e-8d528fa7a71c.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
BERGENBIO - Mandatory notification of trade by Primary Insider
Bergen, Norway, 7 January 2022– BerGenBio ASA (OSE: BGBIO) (the "Company"), has been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has bought 10,000 shares in BerGenBio ASA at an average price of NOK 20.03 per share. After the transaction Mr. Olin holds 18,000 shares in BerGenBio ASA.
Please see the attached document for further details of the transaction.
Contact:
Rune Skeie, CFO, BerGenBio ASA [email protected]
This information is subject to the disclosure requirements pursuant to the EU Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities Trading Act.